Provided by Tiger Trade Technology Pte. Ltd.

Biomerica

2.09
-0.0500-2.34%
Post-market: 2.07-0.0200-0.96%19:48 EDT
Volume:51.13K
Turnover:106.33K
Market Cap:6.46M
PE:-1.35
High:2.16
Open:2.15
Low:2.01
Close:2.14
52wk High:3.22
52wk Low:1.45
Shares:3.09M
Float Shares:2.66M
Volume Ratio:0.07
T/O Rate:1.92%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.5513
EPS(LYR):-2.1649
ROE:-94.32%
ROA:-54.58%
PB:1.95
PE(LYR):-0.97

Loading ...

Biomerica FY26 Net Sales Drop 16% to $4.45 Million; Dividend, Interest and Other Income More than Doubled to $1.23 Million

Reuters
·
6 hours ago

Biomerica CEO Zackary S. Irani Reports Acquisition of $50,000 Common Shares

Reuters
·
Aug 28

Biomerica Announces $2.23 Million Financing

THOMSON REUTERS
·
Aug 27

Biomerica - Financing Priced at $1.60 Per Share with no Warrants or Discount

THOMSON REUTERS
·
Aug 27

Biomerica Completes Private Placement of Equity Securities

TIPRANKS
·
Aug 27

Biomerica Prices 1,393,705-Share Private Placement at $1.6 Per Share, Raising $2.23 Million

Reuters
·
Aug 27

Biomerica Enters Related-Party Deal to Boost Liquidity

TIPRANKS
·
Jun 05

Biomerica signs USD 500,000 secured promissory note with CEO-affiliated buyers at 8% interest

Reuters
·
Jun 05

Biomerica enters master services agreement with life sciences company

TIPRANKS
·
May 28

Biomerica signs CDMO services deal for over $1.75 million in IVD assay development fees

Reuters
·
May 28

Biomerica Lands a $1.75 Million CDMO Master Services Agreement for Ivd Diagnostic Development

THOMSON REUTERS
·
May 28

Biomerica - MSA Establishes Initial Three-Year Term With Automatic One-Year Renewals

THOMSON REUTERS
·
May 28

Biomerica inFoods IBS real-world effectiveness study accepted for DDW 2026 presentation

Reuters
·
Apr 29

Biomerica Announces Medicare Administrative Contractor Confirmation of Individual Claim Review for inFoods® IBS, Opening a Scalable Medicare Commercialization Pathway

GlobeNewswire
·
Apr 16

Biomerica Launches inFoods® IBS in Canada Through Partnerships with Phoenix Airmid Biomedical and CanAlt Health Labs

GlobeNewswire
·
Apr 14

BRIEF-Biomerica Q3 Net Income USD -1.31 Million

Reuters
·
Apr 14

Biomerica Q3 Operating Expenses USD 1.25 Million

THOMSON REUTERS
·
Apr 14

Biomerica Q3 Revenue USD 990 Thousand

THOMSON REUTERS
·
Apr 14

Biomerica Q3 Gross Margin -4%

THOMSON REUTERS
·
Apr 14

Press Release: Biomerica Reports Third Quarter Fiscal 2026 Financial Results

Dow Jones
·
Apr 14